Generated August 18, 2026 at 8:32 PM ET
· Covers August 18 trading day
· 10 of 171 ready 8-Ks selected
· AI-assisted overview
The day's filings were dominated by significant M&A activity, including Metaplanet's $132M investment in Super League Enterprise, Curaleaf's take-over bid for Aurora Cannabis, and Francisco Partners' agreement to acquire Weave Communications. Regulatory and compliance issues were also prominent, with Flotek facing potential termination of its Puerto Rico power contract, CID HoldCo receiving a Nasdaq delisting notice, and Firsthand Technology Value Fund moving to delist and withdraw BDC status. Additionally, XTI Aerospace announced its CEO's resignation amid an internal review, while Amylyx reported positive Phase 3 results for avexitide. Regaining compliance, ZW Data Action received a Nasdaq notice confirming it met the minimum bid price rule.
leadership
negative
materiality 0.85
August 18, 2026, 6:01 AM ET
XTI Aerospace CEO Pomeroy resigns amid internal review; Schneiderman named interim CEO
- Pomeroy resigned Aug 17, 2026 as Chairman/CEO; receives $200K separation and immediate vesting of 2M stock options.
- Independent board committee conducting internal review of matters relating to Pomeroy; timeline not yet determined.
- Jeremy Schneiderman, Drone Nerds CEO since 2014, appointed Interim CEO; $400K base salary, bonus up to 400-500% of base.
FTK
FLOTEK INDUSTRIES INC/CN/
regulatory
negative
materiality 0.90
August 18, 2026, 7:08 AM ET
Flotek's Puerto Rico power contract faces termination; FY2026 guidance reaffirmed
- Oversight Board voted to revoke approval of PREPA contract, directed PREPA to terminate; PREPA ordered work stoppage Aug 17.
- PREPA has not delivered formal termination notice as of Aug 18; Flotek evaluating impact on expected ~$40M annual revenue.
- Short seller with admitted position published report Aug 17 alleging business issues; Flotek believes it aimed to drive down stock.
SLE
Super League Enterprise, Inc.
M&A
positive
materiality 1.00
August 18, 2026, 9:06 AM ET
Metaplanet to invest 2,100 BTC (~$132M) in Super League, forming Superplanet with 95.7% ownership
- Metaplanet to invest 2,100 BTC (~$132.1M) plus $2.5M cash for 44,859,400 SLE shares at $3.00/share.
- Upon close, SLE renamed Superplanet, Inc. (ticker SUPA), becomes consolidated Metaplanet subsidiary; Metaplanet holds ~95.7% (~93.6% as adjusted).
- Metaplanet gets 100 convertible perpetual preferred shares with majority director designation rights and 10-year warrants for up to 381M shares at $3.00-$33.50.
CURLF
Curaleaf Holdings, Inc.
M&A
positive
materiality 0.90
August 18, 2026, 9:16 AM ET
Curaleaf launches formal take-over bid for Aurora Cannabis at $4.00/share, 45% premium
- Offer: 0.3463 Curaleaf shares + US$0.75 cash per Aurora share, total ~US$4.00, 45% premium to unaffected price.
- Ex-cash premium 110%; based on Aurora's US$109M cash ($1.62/sh) and US$2.75 30-day VWAP.
- Offer expires 5:00 pm MT Dec 1, 2026; subject to >50% tender, 66⅔% fully diluted, regulatory approvals.
WEAV
Weave Communications, Inc.
M&A
positive
materiality 0.90
August 18, 2026, 9:01 AM ET
Weave to be acquired by Francisco Partners for $7.40/share cash, ~$650M equity value
- Stockholders receive $7.40/share cash, ~34% premium to Aug 17, 2026 close.
- Aggregate equity valuation ~$650M; deal unanimously approved by Weave board.
- Expected to close Q4 2026, subject to stockholder and regulatory approvals.
ONCY
ONCOLYTICS BIOTECH INC
regulatory
positive
materiality 0.75
August 18, 2026, 9:03 AM ET
Oncolytics aligns with FDA on pivotal Part B expansion for REO 033 colorectal cancer study
- FDA written feedback supports potential pivotal Part B expansion of REO 033 in 2L RAS-mutant MSS colorectal cancer.
- Alignment on accelerated approval based on objective response rate; progression-free survival supports full approval.
- Company to skip scheduled Type D meeting; will pursue End-of-Phase meeting for final registration program agreement.
other material
negative
materiality 1.00
August 18, 2026, 5:02 PM ET
CID HoldCo faces Nasdaq delisting and LHT I foreclosure on $1.06M default
- On Aug 12, 2026, Nasdaq issued additional delisting basis: MVPHS below $15M for 30 days; failed to regain by Aug 10, 2026.
- Initial delisting notice Aug 6, 2026 for failure to meet $50M MVLS requirement; hearing requested and pending.
- LHT I (assignee of J.J. Astor & Co.) sent default notice Aug 12, 2026 alleging breach of Note; default amount $1,057,417.37.
CNET
ZW Data Action Technologies Inc.
regulatory
positive
materiality 0.50
August 18, 2026, 4:05 PM ET
ZW Data Action regains Nasdaq minimum bid price compliance
- Nasdaq notified company on Aug 17, 2026 it regained compliance with Listing Rule 5550(a)(2).
- Closing bid price was at or above $1.00 for 10 consecutive business days, Aug 3-14, 2026.
- Prior deficiency from March 26, 2026 letter is now closed; no further action required.
SVVC
Firsthand Technology Value Fund, Inc.
other material
negative
materiality 0.90
August 18, 2026, 5:03 PM ET
Firsthand Technology Value Fund to delist, withdraw BDC status, pursue liquidation
- Directors Greg Burglin and Kimun Lee resigned Aug 17, 2026; Kevin Landis remains sole director.
- CCO Nichole Mileski and Secretary Kelvin Leung resigned; Landis adds Secretary role.
- Company to file Form N-54C before Aug 31, 2026 to withdraw BDC election.
AMLX
Amylyx Pharmaceuticals, Inc.
other material
positive
materiality 0.85
August 18, 2026, 7:09 AM ET
Amylyx reports positive Phase 3 LUCIDITY results for avexitide in post-bariatric hypoglycemia
- LUCIDITY met primary endpoint: 55% reduction in composite Level 2/3 hypoglycemic events vs placebo (p=0.000003).
- All secondary endpoints met: reductions in SMBG-measured Level 2, CGM-measured Level 2, and adjudicated Level 3 events.
- Trial enrolled 78 adults with PBH post-RYGB; randomized 3:2 to 90 mg avexitide SC daily or placebo.